CADENCE Trademark

Trademark Overview


On Thursday, July 8, 2010, a trademark application was filed for CADENCE with the United States Patent and Trademark Office. The USPTO has given the CADENCE trademark a serial number of 85080692. The federal status of this trademark filing is ABANDONED - EXPRESS as of Friday, October 15, 2010. This trademark is owned by Osiris Therapeutics, Inc.. The CADENCE trademark is filed in the Pharmaceutical Products category with the following description:

Human allograft tissue
cadence

General Information


Serial Number85080692
Word MarkCADENCE
Filing DateThursday, July 8, 2010
Status601 - ABANDONED - EXPRESS
Status DateFriday, October 15, 2010
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesHuman allograft tissue

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, July 13, 2010
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameOsiris Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressColumbia, MD 21046

Trademark Events


Event DateEvent Description
Friday, October 15, 2010ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT
Friday, October 15, 2010ABANDONMENT - EXPRESS MAILED
Thursday, October 14, 2010TEAS EXPRESS ABANDONMENT RECEIVED
Tuesday, July 13, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, July 12, 2010NEW APPLICATION ENTERED IN TRAM

Related Keywords


cadence tissue allograft human